Literature DB >> 10962408

Predicting long-term functional results after myocardial revascularization in ischemic cardiomyopathy.

G B Luciani1, G Montalbano, G Casali, A Mazzucco.   

Abstract

OBJECTIVE: The goal of the present study was to define the early and late functional results after revascularization in ischemic cardiomyopathy and to identify variables predictive of a favorable outcome.
METHODS: A retrospective review of all consecutive patients with ischemic cardiomyopathy undergoing myocardial revascularization between January 1991 and June 1998 was undertaken. One hundred sixty-seven patients (140 men) aged 60 +/- 8 years (range, 39-77 years) with angina (n = 107), congestive heart failure (n = 54), or silent ischemia (n = 6) were identified. One hundred six (63%) patients with angina were in Canadian Cardiovascular Society class III or IV, and 40 (24%) patients with congestive failure were in New York Heart Association class III or IV. The preoperative left ventricular ejection fraction averaged 0.28 +/- 0.05 (range, 0.16-0. 30). Thirteen (8%) patients required preoperative mechanical life support. A mean of 2.9 +/- 0.9 grafts per patient were performed, with an average myocardial ischemia time of 53 +/- 23 minutes and bypass time of 104 +/- 31 minutes.
RESULTS: There were 3 (1.7%) early deaths and 21 (13%) deaths during follow-up (2.7 +/- 2.1 years; range, 0.3-7.8 years), producing a survival of 94% +/- 2% and 75% +/- 10% at 1 and 5 years, respectively. Despite a significant increase in left ventricular ejection fraction (0.28 +/- 0.05 vs 0. 38 +/- 0.09, P =.0001), only 89 (54%) patients were symptom-free at follow-up. Freedom from recurrent angina was 98% +/- 1% and 81% +/- 8%, whereas freedom from congestive failure was 78% +/- 11% and 47% +/- 20% at 1 and 5 years, respectively. Follow-up New York Heart Association class in patients with congestive failure was improved (40/54 class III-IV vs 11/54 class III-IV, P =.0001). Multivariate analysis showed a lower ejection fraction (P =.01), preoperative congestive failure (P =.03), and a need for preoperative intra-aortic balloon pumping (P =.03) to be associated with a greater prevalence of recurrent congestive failure, whereas male sex (P =.01), preoperative angina (P =.04), use of the internal thoracic artery (P =.03), and higher number of grafts (P =.01) were associated with lower prevalence. Male sex (P =.06), higher number of grafts (P =.04), and shorter duration of myocardial ischemia (P =. 04) were also predictive of improvement in New York Heart Association class at follow-up.
CONCLUSIONS: Despite satisfactory early and late survival, late functional outcome after myocardial revascularization in ischemic cardiomyopathy remains suboptimal because of recurrence or persistence of congestive failure. Selection of appropriate surgical candidates and extensive use of complete revascularization with the internal thoracic artery may substantially improve functional results.

Entities:  

Mesh:

Year:  2000        PMID: 10962408     DOI: 10.1067/mtc.2000.108692

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  12 in total

1.  Is severely left ventricular dysfunction a predictor of early outcomes in patients with coronary artery bypass graft?

Authors:  Seyed Hossein Ahmadi; Abbasali Karimi; Namvar Movahedi; Mahmood Shirzad; Mehrab Marzban; Mokhtar Tazik; Hermineh Aramin; Samaneh Dowlatshahi; Mahmood Sheikh Fathollahi
Journal:  Heart Asia       Date:  2010-07-29

Review 2.  Ventricular structure and surgical history.

Authors:  Gerald Buckberg
Journal:  Heart Fail Rev       Date:  2004-10       Impact factor: 4.214

3.  Surgical ventricular restoration: the RESTORE Group experience.

Authors:  Constantine L Athanasuleas; Gerald D Buckberg; Alfred W H Stanley; William Siler; Vincent Dor; Marisa DiDonato; Lorenzo Menicanti; Sergio Almeida de Oliveira; Friedhelm Beyersdorf; Irving L Kron; Hisayoshi Suma; Nicholas T Kouchoukos; Wistar Moore; Patrick M McCarthy; Mehmet C Oz; Francis Fontan; Meredith L Scott; Kevin A Accola
Journal:  Heart Fail Rev       Date:  2004-10       Impact factor: 4.214

4.  Preoperative ejection fraction as a predictor of survival after coronary artery bypass grafting: comparison with a matched general population.

Authors:  Mohamed A Soliman Hamad; Albert H M van Straten; Jacques P A M Schönberger; Joost F ter Woorst; Andre M de Wolf; Elisabeth J Martens; André A J van Zundert
Journal:  J Cardiothorac Surg       Date:  2010-04-23       Impact factor: 1.637

5.  Surgical ventricular restoration: an operation to reverse remodeling - the basic science (part I).

Authors:  Ganesh Shanmugam; Imtiaz S Ali
Journal:  Curr Cardiol Rev       Date:  2009-11

Review 6.  Role of cardiac surgery in the post-myocardial infarction patient with heart failure.

Authors:  Marzia Leacche; Jorge M Balaguer; John G Byrne
Journal:  Curr Heart Fail Rep       Date:  2008-12

7.  Coronary surgery with non-cardioplegic methods in patients with advanced left ventricular dysfunction: immediate and long term results.

Authors:  P E Antunes; J M Ferrão de Oliveira; M J Antunes
Journal:  Heart       Date:  2003-04       Impact factor: 5.994

8.  The efficacy of mitral valve surgery in children with dilated cardiomyopathy and severe mitral regurgitation.

Authors:  John P Breinholt; Charles D Fraser; William J Dreyer; Anthony C Chang; E O'Brian Smith; Jeffrey S Heinle; E Dean McKenzie; Sarah K Clunie; Jeffrey A Towbin; Susan W Denfield
Journal:  Pediatr Cardiol       Date:  2007-09-11       Impact factor: 1.655

9.  Effects of myocardial viability and left ventricular remodeling on survival of patients with heart failure and reduced ejection fraction after coronary artery bypass grafting.

Authors:  Jian Cao; Ran Dong; Kui Zhang; Hongjia Zhang
Journal:  Cardiovasc Diagn Ther       Date:  2020-04

10.  Efficacy of aneurysmectomy in patients with severe left ventricular dysfunction: favorable short-and long-term results in ischemic cardiomyopathy.

Authors:  Carlos Vicente Serrano; José A F Ramires; Alexandre de Matos Soeiro; Luiz Antônio M César; Whady A Hueb; Luiz A Dallan; Fábio B Jatene; Noedir A G Stolff
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.